Trial · NCT07421869
SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial
NCT07421869, Not applicable, Recruiting, Seoul National University Bundang Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial. Trials, record NCT07421869. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07421869
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial
- NCT number
- NCT07421869
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 107 participants, estimated
- Lead sponsor
- Seoul National University Bundang Hospital
- Conditions
- Hypothyroidism
- Interventions
- Levothyroxine tapering
- First posted
- 2026-02-19
- Last updated
- 2026-02-19
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of participants who maintain discontinuation of levothyroxine for at least 6 months | Up to 6 months after levothyroxine discontinuation | The number and proportion of participants who are able to remain off levothyroxine for at least 6 consecutive months without requiring re-initiation of treatment due to abnormal thyroid function (serum TSH level ≥10 μIU/mL). |
| Secondary | Proportion of participants who can discontinue levothyroxine | up to 3 years after study enrollment | The number and proportion of participants who were able to discontinue levothyroxine after dose reduction during the study follow-up period, regardless of whether the discontinuation was sustained. This includes any participant who temporarily stopped levothyroxine for any duration, even if the medication was later resumed. |
| Secondary | Proportion of participants who maintain discontinuation of levothyroxine for at least 12 months | Up to 12 months after levothyroxine discontinuation | The number and proportion of participants who are able to remain off levothyroxine for at least 12 consecutive months without requiring re-initiation of treatment due to abnormal thyroid function (serum TSH level ≥10 μIU/mL). |
| Secondary | Proportion of participants who maintain discontinuation of levothyroxine for at least 36 months | Up to 36 months after levothyroxine discontinuation | The number and proportion of participants who are able to remain off levothyroxine for at least 36 consecutive months without requiring re-initiation of treatment due to abnormal thyroid function (serum TSH level ≥10 μIU/mL). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07421869
GET https://conductscience.org/api/trials/v1/NCT07421869/registered